She founded Force Therapeutics to solve her own patients’ care delivery challenges and help them stay connected and in control of their care. Prior to founding Force Therapeutics, Bronwyn ran ...
BMO Capital Markets initiated coverage on Dyne Therapeutics, Inc. (NASDAQ:DYN), focused on developing therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback